Predictions
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.91
13.08.22
13.08.22
€1.00
13.08.23
13.08.23
-12.70%
23.08.22
23.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.72
07.08.22
07.08.22
-
07.08.23
07.08.23
-13.98%
26.08.22
26.08.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€157.25
29.07.22
29.07.22
€200.00
29.07.23
29.07.23
14.87%
30.07.23
30.07.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Medtronic plc
Start price
Target price
Perf. (%)
€91.39
27.07.22
27.07.22
€100.00
27.07.23
27.07.23
-11.48%
28.07.23
28.07.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€44.85
27.07.22
27.07.22
€60.00
27.07.23
27.07.23
5.35%
27.07.23
27.07.23
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
Stratec SE
Start price
Target price
Perf. (%)
€85.00
26.07.22
26.07.22
€66.00
26.07.23
26.07.23
4.94%
06.08.22
06.08.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
US Physical Therapy Inc.
Start price
Target price
Perf. (%)
€122.00
26.07.22
26.07.22
-
26.07.23
26.07.23
-9.84%
26.07.23
26.07.23
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€154.40
23.07.22
23.07.22
€170.00
23.08.22
23.08.22
5.63%
11.08.22
11.08.22
Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
Sartorius AG VZO
Start price
Target price
Perf. (%)
€418.20
22.07.22
22.07.22
€550.00
22.07.23
22.07.23
-23.00%
30.05.23
30.05.23
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€146.15
15.07.22
15.07.22
€155.00
15.07.23
15.07.23
5.64%
23.07.22
23.07.22
Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€146.15
15.07.22
15.07.22
€175.00
15.07.23
15.07.23
21.16%
16.07.23
16.07.23
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€235.25
13.07.22
13.07.22
€239.00
13.07.23
13.07.23
-1.59%
13.07.23
13.07.23
Fluidigm Corp.
Start price
Target price
Perf. (%)
€1.68
27.06.22
27.06.22
-
27.06.23
27.06.23
-10.79%
24.04.23
24.04.23
Probably not worthwhile Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.24
24.06.22
24.06.22
€5.00
24.06.23
24.06.23
-1.57%
26.06.22
26.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.77
10.06.22
10.06.22
€0.20
10.06.23
10.06.23
24.58%
26.06.22
26.06.22
Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€49.15
01.06.22
01.06.22
-
01.06.23
01.06.23
-2.34%
11.06.22
11.06.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€42.25
01.06.22
01.06.22
-
01.06.23
01.06.23
-0.47%
11.06.22
11.06.22
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Bovie Medical Corp
Start price
Target price
Perf. (%)
€5.90
28.05.22
28.05.22
-
28.05.23
28.05.23
-55.93%
24.04.23
24.04.23
Risky Investment
Vita 34 AG
Start price
Target price
Perf. (%)
€11.05
18.05.22
18.05.22
-
18.05.23
18.05.23
-0.45%
28.05.22
28.05.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€471.15
17.05.22
17.05.22
-
17.05.23
17.05.23
-6.19%
17.05.23
17.05.23
Teladoc Health Inc
Start price
Target price
Perf. (%)
€30.42
16.05.22
16.05.22
-
16.05.25
16.05.25
-53.44%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€5.42
15.05.22
15.05.22
-
15.05.23
15.05.23
81.90%
24.04.23
24.04.23
Risky Investment